Viewing Study NCT00803920


Ignite Creation Date: 2025-12-25 @ 4:15 AM
Ignite Modification Date: 2025-12-26 @ 3:15 AM
Study NCT ID: NCT00803920
Status: COMPLETED
Last Update Posted: 2015-12-03
First Post: 2008-12-04
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Continuous Glucose Monitoring (CGM) in Subjects With Type 2 Diabetes Taking Twice-Daily Exenatide or Once-Weekly Exenatide
Sponsor: HealthPartners Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module